BIO-Key International Inc
F:BJO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
BIO-Key International Inc
F:BJO
|
US |
|
F
|
Fresenius SE & Co KGaA
DUS:FRE
|
DE |
|
John Wiley & Sons Inc
F:2F7
|
US |
BIO-Key International Inc
BIO-key International makes identity and access management software that helps organizations verify users before giving them access to systems, apps, and data. Its core products use biometrics, such as fingerprint and other multi-factor login methods, along with passwordless and single sign-on tools. The company sells mainly to businesses, schools, government agencies, and other organizations that need stronger security for employees, students, and contractors. The company makes money by licensing its software, selling subscriptions, and charging for related services such as deployment and support. Customers use BIO-key to reduce password problems, tighten security, and manage logins across many devices and systems from one control point. That makes BIO-key a specialist in the security stack rather than a broad IT vendor. What sets the business apart is its focus on biometric authentication and identity proofing. Instead of trying to do every kind of cybersecurity tool, BIO-key centers on the first step in security: confirming who a user is. That role matters most in environments where stolen passwords are a major risk and where organizations want a simpler way to control access without adding friction for end users.
BIO-key International makes identity and access management software that helps organizations verify users before giving them access to systems, apps, and data. Its core products use biometrics, such as fingerprint and other multi-factor login methods, along with passwordless and single sign-on tools. The company sells mainly to businesses, schools, government agencies, and other organizations that need stronger security for employees, students, and contractors.
The company makes money by licensing its software, selling subscriptions, and charging for related services such as deployment and support. Customers use BIO-key to reduce password problems, tighten security, and manage logins across many devices and systems from one control point. That makes BIO-key a specialist in the security stack rather than a broad IT vendor.
What sets the business apart is its focus on biometric authentication and identity proofing. Instead of trying to do every kind of cybersecurity tool, BIO-key centers on the first step in security: confirming who a user is. That role matters most in environments where stolen passwords are a major risk and where organizations want a simpler way to control access without adding friction for end users.
Revenue: BIO-key said Q1 revenue rose 34% to $2.1 million, helped by a renewed 1-year software license from a long-time banking customer and stronger hardware sales.
Profitability: Gross margin held at 82%, and the company cut its net loss to $165,036 from $736,545 a year ago.
Outlook: Management said it expects to be profitable and cash flow positive in Q2 and feels confident in the first half and the rest of 2026.
Growth Drivers: Defense, financial services, and EMEA traction were highlighted as the main demand drivers, along with new channel partners in India, Vietnam, and the U.S. public sector through DLT Solutions.
NASDAQ Plan: The company said its appeal hearing is set for June 16 and it is aiming to regain NASDAQ compliance, with a possible return in late June or July.
Cash Position: Management said the balance sheet is solid, with book value of $7.6 million and cash of a little over $2 million, and said funding is not an issue.
